title: Phytotherapy of benign prostatic hyperplasia. A minireview.
abstract: Benign prostate hyperplasia (BPH) is a common condition affecting older men, with an incidence that is age-dependent. Histological BPH, which typically develops after the age of 40 years, ranges in prevalence from >50% at 60 years to as high as 90% by 85 years of age. Typical symptoms include increased frequency of urination, nocturia, urgency, hesitancy, and weak urine stream. Conventional medicines used for the treatment of BPH include alpha blockers and 5-alpha reductase inhibitors. This articles review the mode of action, the efficacy, and the safety, including herb-drug interactions of the most common botanicals (Serenoa repens, Pygeum africanum, Urtica dioica, and Cucurbita pepo) and nutraceuticals (isoflavones, lycopene, selenium, and β-Sitosterol) in controlling the lower urinary tract symptoms associated to BPH.
authors.forename: Ester
authors.initials: E
authors.lastname: Pagano
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Laudato
authors.forename: Michele
authors.initials: M
authors.lastname: Griffo
authors.forename: Raffaele
authors.initials: R
authors.lastname: Capasso
mesh_terms: D019587:Dietary Supplements; D006801:Humans; D008297:Male; D008517:Phytotherapy; D011470:Prostatic Hyperplasia / Q000188:drug therapy*